Q&A With Jim Januzzi From Massachusetts General Hospital: Using Biomarkers To Learn More About Heart Failure

Video

Treating heart failure can be a delicate practice for doctors depending on the severity of the condition. Finding new ways to help these patients is moving from the clinical side of medicine into the laboratory to find more exacting treatment methods.

Treating heart failure can be a delicate practice for doctors depending on the severity of the condition. Finding new ways to help these patients is moving from the clinical side of medicine into the laboratory to find more exacting treatment methods.

James (Jim) Januzzi, MD, from Massachusetts General Hospital discussed work being done in this field during the American Heart Association's Annual Scientific Sessions in Orlando.

Patients with chronic heart failure may not always be at risk of a fatal cardiac event but there has not been a clear diagnosis of what worsening heart failure means. Researchers are looking to find more definitive answers for these and other questions.

Related Videos
Kelley Branch, MD, MS | Credit: University of Washington Medicine
David Berg, MD, MPH | Credit: Brigham and Women's
HCPLive Five at ACC 2024 | Image Credit: HCPLive
Ankeet Bhatt, MD, MBA | Credit: X.com
Ankeet Bhatt, MD, MBA | Credit: X.com
Sara Saberi, MD | Credit: University of Michigan
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Albert Foa, MD, PhD | Credit: HCPLive
Veraprapas Kittipibul, MD | Credit: X.com
Heart Failure stock imagery. | Credit: Fotolia
© 2024 MJH Life Sciences

All rights reserved.